Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00

АШУҮИС — Судалгааны мэдээлэл (CRIS)

Permanent URI for this communityhttps://library.mnums.edu.mn/handle/123456789/5001

Browse

Search Results

Now showing 1 - 5 of 5
  • Some of the metrics are blocked by your 
    Item type:Publication,
    The Potential Effect of Traditional Herbal Medicine on Bile Flow in CC14-Induced Liver Injury Model
    (Mongolian National University of Medical Sciences, 2024-09-27) ;
    Tuul Khalzaibaast
    ;
    ; ;
    Chimedragchaa Chimedtseren
    Objective: To investigate whether the modified Mongolian traditional medicine Yaman Serdeg-3 (NYS-3) effects the biliary excretion in the carbon tetrachloride-induced liver injury model. Methods: Forty-seven male and female Sprague-Dawley rats were divided into 5 groups: Group I healthy group (n=12); Group II healthy group + NYS-3 (n=9); Group III liver injury model (n=10); Group IV liver injury model + Chinese medicine Hua gan Pian (n=10); Group V liver injury model + NYS-3. Experimental groups II-V, received corresponding medicinal preparations for 2 weeks. The dose of Hua gan Pian (HGP) was 0.046g/ml while the dose of NYS-3 was 2.025g/ml. For the acute induction of liver injury, the rats were orally administered 40% CCl4 in olive oil (4 ml/kg) twelve hours after the last administration of preparations. Results: At the first 15-minute interval, the highest bile flow was observed in Group II rats, which were administered NYS-3. This phenomenon continued at the second 15-minute interval, also. However, at the third 15-minute interval, the bile flow decreased sharply in Group II. On the other hand, in the liver injury model, untreated or pre-treated rats had significantly different bile flows. For example, in the first half of the experiment, both non-treated and HGP pre-treated groups had similar bile flow, while, the group pre-treated with NYS-3 had significantly low bile flow. Then, after 45 minutes of the experiment, the bile flow became similar amounts in both pre-treated groups. Conclusion: We conclude that the NYS-3 administration had increased the bile flow at 3rd 15min of interval, which is higher than positive control group where liver injury model rats received HGP.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    The hyperplasia of the mammary gland effect of the Mongolian Remedy RuXian-I in rats reduced by estrogen and progesterone via inhibition of MAPK and NF-κB pathways
    (2024-04-28)
    Shuangquan Zhao
    ;
    Chimedragchaa Chimedtseren
    ;
    ; ;
    Bin Zhang
    Background: The aim of the present study was to evaluate whether the HMG (Hyperplasia of the Mammary Gland) effect of RuXian-I in estrogen- and progestogen- induced HMG rats is mediated through the activation of MAPK (Mitogen activated protein kinase) and NF-κB signaling pathways. Materials and methods: Fifty virgin female Wistar rats were randomly divided into in control and HMG, RuXian-I (0.75 g·kg−1, 1.5 g·kg−1, 3 g·kg−1, respectively) groups, 10 in each. Injections of estrogen and progestogen were given to establish rat models of HMG and RuXian-I at the same time. Changes in nipple heights were measured; pathologic changes of HMG in rats were also observed under a light microscope; the phosphorylation levels of MAPK and NF κB and the expression levels of TNF-α and IL-1β were measured. Results: Compared with the control group, the nipple diameters and height were increased significantly, the numbers of MG lobules were increased, there were changes in breast histopathology, the levels of TNF-α and IL-1β increased significantly, and MAPK and NF-κB were activated in HMG rats. Compared with the HMG model group, the increased nipple height was decreased, the numbers of MG lobules were reduced, the degree of HMG in rats was alleviated obviously, and the phosphorylation level of MAPK and NF-κB and cytokines TNF- α and IL-1β levels in serum were decreased by RuXian-I treatment. Conclusion: Those results suggest RuXian-I has protective and therapeutic effects on HMG rats induced by estrogen and progestogen and is likely to activate MAPK and NF-κB signaling pathways.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Using Network Pharmacology to Clarify the Therapeutic Mechanism of Hataagqi-19 Hot Compress Therapy in Rats with Lumbar Disc Herniation
    (Mongolian National University of Medical Sciences, 2021-07-01)
    Aruhan
    ;
    Byambasuren Dorjsuren
    ;
    Chimedragchaa Chimedtseren
    ;
    Objective: This study aims to determine the primary efficacy of traditional medicine treatment of Lumbar disc herniation (LDH) and the effect of Hataagqi-19 hot compress (H19+HC) therapy on LDH rats. Methods: Referencing ancient books of Mongolian medicine, we studied the theoretical basis of Mongolian medicine to treat LDH. We performed operations to establish a model of SD rats with LDH treated with H19+HC. Paw withdrawal threshold (PWT) was detected, serum TNF-α, IL-6, and IL-1β were measured by ELISA, and immunohistochemical staining was used to measure IL-6, CD68, and IgG. Results: The medicinal properties of the drugs for the treatment of LDH are mainly dry “Xieriwusu,” heat-clearing, and suppressing “Heyi” medicine. The PWT value, serum TNF-α, IL-6, IL-1β and tissue IL-6, CD68, IgG of H19+HC was lower than that of the control group. The nucleus pulposus of the H19+HC was significantly smaller than that of the control group. The positive staining result in the main inflammatory cells of the lesion was CD68. Conclusions: Mongolian medicine treatment of LDH is based on the dry “Xieriwusu,” heat-clearing, and suppressing “Heyi” efficacy. The H19+HC therapy follows this efficacy and has the effects of improved abnormal behavior, analgesic, anti-inflammatory, and reabsorption of the nucleus pulposus.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Hepatoprotective Activity of the Traditional Multicomponent Formulation Gurgem-13 on Carbon Tetrachloride (CCL4) Induced Experimental Liver Injury in Rats
    (Mongolian National University of Medical Sciences, 2019-12-29) ;
    Chimedragchaa Chimedtseren
    ;
    ;
    Altantsetseg Altangerel
    Objectives: The purpose of present study was intended to evaluate hepatoprotective effects of traditional multicomponent formulation Gurgum13 on carbon tetrachloride (CCI4) induced liver injury model in rats. Methods: Chronic toxic liver injury was induced experimentally by intraperitoneal injection (IP) of 1.0 ml/kg body weight of 10% carbon tetrachloride (CCI4) three times per week for duration of three months in rats. A total of five groups of animals with 15 rats in each were used for the experiment. Group 1 was as a normal control (intact). Group 2 served as a control group received CCI4 1.0 ml/kg IP three times a week for 3 months. Group 3, 4 and 5 were as the treatment groups received CCI4 1 ml/kg IP and administered traditional multicomponent formulation Gurgum-13 as a test drug (100 mg/kg) for 3 months daily. Milk thistle (50 mg/kg) and Lilicoaguliant (LLC) (100 mg/kg) were given daily for 3 months as a reference drug respectively. The activity of Gurgum-13 formulation and other comparative drugs were investigated with the dynamic study of liver marker enzymes, AST, ALT, ALP, bilirubin, and the antioxidant and blood coagulating effects of the remedy, which were studied in three months of experimentation. Gurgum-13 is one of the Mongolian traditional multicomponent formulation used in practice for a range of diseases including liver disorders. Results: Carbon tetrachloride significantly decreased the liver functions as assessed through an increase in blood serum and liver marker enzymes in control groups. Gurgum-13 treatment significantly prevented hepatotoxicity of carbon tetrachloride by reducing ALT, AST, ALP marker enzymes and bilirubin in blood serum and liver tissue in the three months period of chronic hepatitis (p<.05) similar to reference drugs. The result of the study revealed that Gurgum-13 is significant hepatoprotective against liver injury from CCI4 induced hepatotoxicity by having antioxidant effect and decreasing lipid peroxidation in liver. Conclusion: Multicomponent traditional formulation Gurgum-13 demonstrated very good hepatoprotective effect against CCI4 induced liver injury in rats. Thus, Gurgum-13 can be an effective remedy for the treatment of chronic hepatitis and biliary tract disorders.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Traditional Mongolian medicine RuXian-1 suppress the breast hyperplasia by GRP78/PERK/CHOP pathway in rat model
    (2024-08-30)
    Shuangquan Zhao
    ;
    Chimedragchaa Chimedtseren
    ;
    ;
    In this study we aimed to study the protective effect of RuXian-1, which is a traditional Mongolian medicine on hyperplasia of mammary glands in rats and to explore its possible mechanism. Methods: The rat model of breast hyperplasia was induced by intramuscular injection of estradiol benzoate. The rats were randomly divided into 4 groups: saline treatment group (negative control), estrogen treatment group (model group), RuXian-1 treatment group and raloxifene treatment group (positive control). RuXian-1 group and raloxifene group were given 3.0 g/kg of RuXian-1 and 1.8 mg/kg of raloxifene daily for 4 weeks, respectively. After treatment, the breast tissue of each group was harvested and confirmed the expressions levels of glucose-related protein 78 (GRP78), C/EBP homologous protein (CHOP), and protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) which were known that functions as an endoplasmic reticulum stress marker by Western blotting. Results: Compared with the normal group, the GRP78, PERK and CHOP protein levels in the breast tissue of the model group were significantly decreased. Compared with the model group, the expression of GRP78, PERK and CHOP in RuXian-1 group significantly increased, the expression of GRP78 and CHOP of raloxifene significantly increased (p < 0.05), and the expression of PERK did not change. Conclusion: The Mongolian medicine RuXian-1 has therapeutic effect on mammary hyperplasia in rats, and its therapeutic mechanism is related to activating the GRP78/PERK/CHOP signaling pathway and promoting mammary gland cell apoptosis.
    Scopus© Citations 1